NASDAQ Biotechnology 차트 - Investing.com
NASDAQ Biotechnology 차트 - Investing.com
Jan 8, 2013
investing.com
iShares Nasdaq Biotechnology ETF Experiences Big Outflow
iShares Nasdaq Biotechnology ETF Experiences Big Outflow
Oct 10, 2019
nasdaq.com
Trinity Biotech (Nasdaq: TRIB) 30-Second Investor Summary: AI Glucose Wearable Platform | RedChip Companies
Trinity Biotech (Nasdaq: TRIB) 30-Second Investor Summary: AI Glucose Wearable Platform | RedChip Companies
7K views1 month ago
linkedin.com
FibroBiologics (Nasdaq: FBLG) 30 Second Investor Overview | IP Portfolio and Cell Science Platform | RedChip Companies
FibroBiologics (Nasdaq: FBLG) 30 Second Investor Overview | IP Portfolio and Cell Science Platform | RedChip Companies
6.7K views3 months ago
linkedin.com
Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a B2i Digital Featured Company, announced that management will present at the BIO Investment and Growth Summit 2026, hosted by the Biotechnology Innovation Organization (BIO), taking place March 2 to 3, 2026, in Miami Beach, Florida. The Company’s corporate presentation is scheduled for March 2, 2026, at 2:30 PM Eastern. At BIO, Jupiter will discuss its FDA-cleared Phase IIa clinical program in Parkinson’s disease. The U.S. Food and Drug Administration
0:25
Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a B2i Digital Featured Company, announced that management will present at the BIO Investment and Growth Summit 2026, hosted by the Biotechnology Innovation Organization (BIO), taking place March 2 to 3, 2026, in Miami Beach, Florida. The Company’s corporate presentation is scheduled for March 2, 2026, at 2:30 PM Eastern. At BIO, Jupiter will discuss its FDA-cleared Phase IIa clinical program in Parkinson’s disease. The U.S. Food and Drug Administration
1.2K views1 month ago
FacebookB2i Digital
NovaBridge Biosciences(NasdaqGM: NBP) added to NASDAQ Biotechnology Index
NovaBridge Biosciences(NasdaqGM: NBP) added to NASDAQ Biotechnology Index
3 months ago
marketscreener.com
Nasdaq Explained: History, Trading System, and Financial Insights
Nasdaq Explained: History, Trading System, and Financial Insights
Mar 20, 2024
investopedia.com
IGM Biosciences, Inc.(NasdaqGS: IGMS) dropped from NASDAQ Biotechnology Index
8 months ago
marketscreener.com
Invesco Nasdaq Biotechnology ETF Rings the Nasdaq Stock Market Opening Bell
Jan 8, 2024
nasdaq.com
Biotechnology
Mar 23, 2020
gatech.edu
Introduction to Biotechnology
Apr 30, 2021
carolina.com
Upstream Bio Rings the Nasdaq Stock Market Opening Bell
Oct 23, 2024
nasdaq.com
Nasdaq Financial Technology News & Insights
Nov 15, 2024
nasdaq.com
Abivax va intégrer l'indice américain Nasdaq Biotechnology
3 months ago
zonebourse.com
Biotechnology and Synthetic Biology
Nov 23, 2023
stanford.edu
Biotechnology Master's Degree Program | Harvard Extension School
4 months ago
harvard.edu
Biotechnology Innovation Organization | LinkedIn
Jan 6, 2016
linkedin.com
BioNTech SE Rings the Opening Bell in Celebration of its IPO
Oct 11, 2019
nasdaq.com
0:34
At Nasdaq, we have disruption in our DNA, and we’re proud to be the home to nearly 96% of today’s top and emerging US-listed biotech companies. 🧬 In honor of the 42nd Annual J.P. Morgan Healthcare Conference & the innovative healthcare sector, Nasdaq's Jeff Thomas, Invesco US & other healthcare trailblazers, open the U.S. markets. #NationalBiotechnologyMonth | Nasdaq
351 viewsJan 8, 2024
FacebookNasdaq
0:15
🔬@Nasdaq remains home to today’s top & emerging biotech companies. Here’s what you need to know about the latest trends shaping the biotech sector in 2025 from Jordan Saxe, Head of Healthcare Listings at Nasdaq. Read more at the #LinkInBio. | Nasdaq
731 viewsMar 10, 2025
FacebookNasdaq
Trends in Biotechnology
9 months ago
deloitte.com
Sana joins Nasdaq with blockbuster $587M IPO
Feb 4, 2021
geekwire.com
0:20
Unicycive Therapeutics (Nasdaq: UNCY) recently released an updated company presentation highlighting several financial aspects of the biotechnology company. Unicycive Therapeutics is a B2i Digital Featured Company. View their comprehensive profile at https://b2idigital.com/unicycive. Highlights from the investor presentation include: • Unaudited cash and cash equivalents of $22.3 million as of June 30, 2025 • Cash runway currently expected into 2H 2026 • Potential future funding of up to $102 mi
1.4K views6 months ago
FacebookB2i Digital
NetScientific portfolio company PDS Biotechnology to advance lead candidate PDS0101 with term loan
Sep 19, 2022
proactiveinvestors.com
45:12
BIOTECH GROWTH TRUST (THE) PLC - Investor Presentation
83 views1 month ago
YouTubeInvestor Meet Company
1:28
Cómo invertir en PDS Biotechnology Corporation (PDSB) paso a paso
3 views3 weeks ago
YouTubeAprende a Invertir
11:53
This sector will BOMB the stock market in 2026 (TOP 5)
255 views1 month ago
YouTubeInvestologia
GT Biopharma: Inside This Emerging NK Cell Biotech | RedChip Companies
4 months ago
linkedin.com
9:52
Best Nasdaq-100 ETFs (US and Irish) | QQQ, QQQM ETF
12.3K viewsJul 1, 2022
YouTubeZiet Invests
See more